Today

Agents

Chat

Arena

Discover

More

App

Madrigal Pharmaceuticals Q2 Product Revenue USD 364.252 Million - MDGL News | Rallies

Madrigal Pharmaceuticals Q2 Product Revenue USD 364.252 Million

MDGL•2026-07-30

Q2 financial results

Jul 30 (Reuters) - Madrigal Pharmaceuticals Q2 net income was USD -57.939 million.

Q2 product revenue: USD 364.252 million
Q2 operating expenses: USD 420.56 million
Q2 operating income: USD -56.308 million

Related News

U.S. Stocks on the Move-Fortinet, Regeneron, Cigna

SPY•2026-07-30

Stantec Awarded US$150 Million Joint Venture Contract For Charleston Coastal Storm Risk Management

STN•2026-07-30

US Stocks: US stock futures rise as Microsoft offsets Fed concerns

•

2026-07-30

Gold gains on softer dollar as markets assess Fed stance, Middle East tensions

GLD•2026-07-30

Visa sets dividend at R$ 0.11 per unit for 3Q 2026